Literature DB >> 6157740

A comparative analysis of the cell surface properties of activated vs endogenous mouse natural killer cells.

R Kiessling, E Eriksson, L A Hallenbeck, R M Welsh.   

Abstract

Mouse natural killer (NK) cells can be activated by interferon and by interferon inducers, such as viruses. In the present report we compared the cell surface properties of the nonactivated "endogenous" NK cells from normal mice with NK cells activated in vivo by acute infection with lymphocytic choriomeningitis virus (LCMV) or in vitro by interferon. Several striking differences were found: 1) in vivo LCMV-activated as well as in vitro interferon-activated NK cells were more adherent to nylon wool columns than the endogenous NK cells; 2) activated NK cells were more EA-monolayer adherent than endogenous NK cells; this adherence could be blocked by streptococcal A protein, indicating that activated NK cells expressed greater Fc receptor mediated adherence; 3) LCMV-activated NK cells that passed through nylon wool columns expressed relatively low EA adherence properties; 4) the sensitivity of NK cells to anti-theta serum + complement treatment was increased in spleen cells late after LCMV infection (day 6 to 7) but not in spleen cells early after infection (day 2 to 3); 5) as shown by centrifugal elutriation, LCMV-activated spleens contained a population of large NK cells that were not present among endogenous spleen cells. In contrast to previous reports, these findings show that there are several distinct changes as a result of both long-term in vivo activation or of short-term in vitro activation of NK cells. These changes might functionally be involved in the increased lytic ability of activated NK cells.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6157740

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  Production of cytokines after lipopolysaccharide stimulation of murine spleen cells during lymphoma development in AKR mice.

Authors:  D Vaillier; R Daculsi; E Legrand; B Guillemain
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

2.  Investigation of porcine natural-killer cell activity with reference to African swine-fever virus infection.

Authors:  S G Norley; R C Wardley
Journal:  Immunology       Date:  1983-08       Impact factor: 7.397

3.  Mechanisms of lymphocytic choriomeningitis virus-induced hemopoietic dysfunction.

Authors:  A R Thomsen; P Pisa; K Bro-Jørgensen; R Kiessling
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

4.  Activation and role of natural killer cells in virus infections.

Authors:  C A Biron; R M Welsh
Journal:  Med Microbiol Immunol       Date:  1982       Impact factor: 3.402

5.  Toxoplasma-induced activities of peritoneal and spleen natural killer cells from beige mice against thymocytes and YAC-1 lymphoma targets.

Authors:  T Kamiyama
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

6.  Human spleen cells mediating natural killing: altered natural cytotoxicity of spleen effector cells from patients with carcinoma.

Authors:  S A Ali; C M Hawrylowicz; J Peel; C Griffith; R C Ress
Journal:  J Cancer Res Clin Oncol       Date:  1983       Impact factor: 4.553

7.  Role of natural killer cells in control of cancer metastasis.

Authors:  N Hanna
Journal:  Cancer Metastasis Rev       Date:  1982       Impact factor: 9.264

8.  Adoptive transfer studies demonstrating the antiviral effect of natural killer cells in vivo.

Authors:  J F Bukowski; J F Warner; G Dennert; R M Welsh
Journal:  J Exp Med       Date:  1985-01-01       Impact factor: 14.307

9.  "Anomalous" Thy-1+ killer cells in allogeneic and F1-anti-parental mixed leukocyte culture. Relation to natural killer cells and allospecific cytotoxic T lymphocytes.

Authors:  K Kärre; J K Seeley; E Eriksson; R C Burton; R Kiessling
Journal:  J Exp Med       Date:  1983-02-01       Impact factor: 14.307

10.  Heterogeneity of natural killer cells in the mouse.

Authors:  J A Lust; V Kumar; R C Burton; S P Bartlett; M Bennett
Journal:  J Exp Med       Date:  1981-08-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.